BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 21105870)

  • 1. Factors related to Medicaid payment acceptance at outpatient substance abuse treatment programs.
    Terry-McElrath YM; Chriqui JF; McBride DC
    Health Serv Res; 2011 Apr; 46(2):632-53. PubMed ID: 21105870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug treatment program ownership, Medicaid acceptance, and service provision.
    McBride DC; Chriqui JF; Terry-McElrath YM; Mulatu MS
    J Subst Abuse Treat; 2012 Mar; 42(2):116-24. PubMed ID: 22154032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does state certification or licensure influence outpatient substance abuse treatment program practices?
    Chriqui JF; Terry-McElrath Y; McBride DC; Eidson SS; VanderWaal CJ
    J Behav Health Serv Res; 2007 Jul; 34(3):309-28. PubMed ID: 17592782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identifying and reducing disparities in successful addiction treatment completion: testing the role of Medicaid payment acceptance.
    Guerrero EG; Garner BR; Cook B; Kong Y; Vega WA; Gelberg L
    Subst Abuse Treat Prev Policy; 2017 May; 12(1):27. PubMed ID: 28545551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Organizational and client determinants of cost in outpatient substance abuse treatment.
    Beaston-Blaakman A; Shepard D; Horgan C; Ritter G
    J Ment Health Policy Econ; 2007 Mar; 10(1):3-13. PubMed ID: 17417043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. State policy and practice regarding substance abuse treatment services for medicaid recipients with disabilities.
    Bachman SS; Drainoni ML; Tobias C
    Am J Addict; 2003; 12(2):166-76. PubMed ID: 12746092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Do benefits restrictions limit Medicaid acceptance in addiction treatment? Results from a national study.
    Andrews CM; Grogan CM; Westlake MA; Abraham AJ; Pollack HA; D'Aunno TA; Friedmann PD
    J Subst Abuse Treat; 2018 Apr; 87():50-55. PubMed ID: 29471926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is conventional wisdom wrong? Coverage for substance abuse treatment under Medicaid managed care.
    Maglione M; Ridgely MS
    J Subst Abuse Treat; 2006 Jun; 30(4):285-90. PubMed ID: 16716842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancing access and retention in substance abuse treatment: the role of Medicaid payment acceptance and cultural competence.
    Guerrero EG
    Drug Alcohol Depend; 2013 Oct; 132(3):555-61. PubMed ID: 23669458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mental health and substance abuse treatment utilization among individuals served by multiple public agencies in 3 states.
    Bray JW; Davis KL; Graver L; Schroeder D; Buck JA; Dilonardo J; Vandivort R
    J Behav Health Serv Res; 2005; 32(3):282-93. PubMed ID: 16010184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Do licensing and accreditation matter in outpatient substance abuse treatment programs?
    Wells R; Lemak CH; Alexander JA; Nahra TA; Ye Y; Campbell CI
    J Subst Abuse Treat; 2007 Jul; 33(1):43-50. PubMed ID: 17588488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in Medicaid Acceptance by Substance Abuse Treatment Facilities After Implementation of Federal Parity.
    Geissler KH; Evans EA
    Med Care; 2020 Feb; 58(2):101-107. PubMed ID: 31688556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The employment of nurses in publicly funded substance abuse treatment programs.
    Knudsen HK; Abraham AJ
    J Addict Nurs; 2012 Oct; 23(3):174-80. PubMed ID: 24135687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insights from a national survey into why substance abuse treatment units add prevention and outreach services.
    Wells R; Lemak CH; D'Aunno TA
    Subst Abuse Treat Prev Policy; 2006 Aug; 1():21. PubMed ID: 16887037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selection incentives in a performance-based contracting system.
    Shen Y
    Health Serv Res; 2003 Apr; 38(2):535-52. PubMed ID: 12785560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective contracting in managed care: the case of substance abuse treatment.
    Lemak CH; Alexander JA; D'Aunno TA
    Med Care Res Rev; 2001 Dec; 58(4):455-81. PubMed ID: 11759199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug and alcohol treatment among privately insured patients: rate of specialty substance abuse treatment and association with cost-sharing.
    Stein BD; Zhang W
    Drug Alcohol Depend; 2003 Aug; 71(2):153-9. PubMed ID: 12927653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Access to substance abuse treatment services under the Oregon Health Plan.
    Deck DD; McFarland BH; Titus JM; Laws KE; Gabriel RM
    JAMA; 2000 Oct; 284(16):2093-9. PubMed ID: 11042758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Public sector managed care for substance abuse treatment: opportunities for health services research.
    McCarty D; Argeriou M; Denmead G; Dilonardo J
    J Behav Health Serv Res; 2001 May; 28(2):143-54. PubMed ID: 11338326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adoption and diffusion of evidence-based addiction medications in substance abuse treatment.
    Heinrich CJ; Cummings GR
    Health Serv Res; 2014 Feb; 49(1):127-52. PubMed ID: 23855719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.